2012
Outcomes and Costs of Concomitant Aortic Valve Replacements Associated With a New Sutureless and Collapsed Valve in Italy, France, Germany, and the United Kingdom. ISPOR 15th Annual European Congress, Berlin, Germany, 5-7 November, 2012 (Podium presentation slides) ...
2011
Zaniolo O, Bettoncelli G, Bosio G, Mantovani LG, Pistelli R, Vaghi A, Villa M, Iannazzo S, Bamfi F, Pitrelli A, Frizzo V, Dal Negro RW. How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost? ISPOR 14th Annual European Congress, Madrid, Spain, November, 2011 Iannazzo S, Didoni G, Crocchiolo D. A Budget Impact Model for the Use of Abatacept as a First Biologic Treatment for Rheumatoid...
2011
ReadSacchi V. Gefitinib: a pharmacoeconomic profile of its use in patients with Non Small Cell Lung Cancer EGFR+. Farmeconomia e percorsi terapeutici 2011; 12(2): 77-85 ReadZaniolo O, Iannazzo S, Patrucco GP, Bellini R. Cost-effectiveness evaluations of spinal neuromodulation with ziconotide continuous infusion in cancer pain in a real clinical practice. Farmeconomia e percorsi terapeutici 2011; 12(2): 87-94 ReadZaniolo O, Carsi M, Iannazzo S. Tiotropium bromide in the routine care...
2011
BTS Winter Meeting 2011. London, England, December, 2011 Fundamentals of Health Economics Models – First in Class Drugs, How to Evaluate Their Cost Effectiveness: Real Life Examples for Calcimimetics. 1st Annual Pharmacoeconomics Middle East Forum, Abu Dhabi, UAE, 3rd March, 2011 ...
2010
ReadCapri S, Benucci M, Iannazzo S, Zaniolo O, D’Arpino A. Un modello di Budget Impact per la valutazione economica di tocilizumab come prima linea biologica nei pazienti con artrite reumatoide di grado moderato o severo. Italian Journal of Public Health – Year 8, Volume 7, Number 2, Suppl 2, 2010: S44-53 ReadEandi M, Pradelli L, Iannazzo S, Chiroli S, Pontoriero G. Economic evaluation of cinacalcet in the treatment of...
2010
Valutazione farmacoeconomica dell’uso di tiotropio bromide nel trattamento di lungo termine dei pazienti con BPCO in Italia. 15° Convegno Annuale AIES, Turin, Italy, 1st October, 2010 Amgen Advisory Board: Relationship Between Vascular Calcification and Clinical and Health Economics Outcomes in Dialysis Patients. Zurich, Switzerland, 18th June, 2010 L’importanza dell’adiuvante MF59 nei vaccini influenzali: aggiornamento su sicurezza, efficacia clinica e dati di farmacoeconomia. Congress SItI, Turin, Italy, 25th May, 2010 and Naples, Italy,...
2010
Zaniolo O, Pradelli L. Economic Performance of Dabigatran Etexilate for Primary VTE Prevention Following Total Hip and Knee Replacement Surgery in Italy. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010 Iannazzo S, Pradelli L, Chiroli S. A Cost-Utility Analysis of Cinacalcet in Secondary Hyperparathyroidism (SHPT) in Five European Countries. ISPOR 13th Annual European Congress, Prague, Czech Republic, 6-9 November, 2010 Iannazzo S, Zaniolo O, Giuliani G....
2009
ReadPradelli L, Iannazzo S, Zaniolo O. The Cost Effectiveness and Cost Utility of Valsartan in Chronic Heart Failure Therapy in Italy: A Probabilistic Markov Model. Am J Cardiovasc Drugs 2009; 9: 383-392 ReadSacchi V, Pradelli L. Effectiveness and cost of treatment with maraviroc in HIV infection. Farmeconomia e percorsi terapeutici 2009; 10(4): 149-159 ReadZaniolo O. Dabigatran in the prevention of venous thromboembolism after major orthopedic surgery. Farmeconomia e percorsi...
2009
Valutazione delle strategie di gestione dei pazienti in terapia con anticoagulanti orali. Feder-AIPA congress, Rome, Italy, 12th June, 2009 ...
2009
Eandi M, Pradelli L, Iannazzo S. Alanyl-Glutamine Dipeptide (Dipeptiven®) in Total Parenteral Nutrition (TPN) Therapy in Critically Ill Italian Patients: a Pharmacoeconomic Simulation Model. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009 Iannazzo S, Pradelli L, Perachino M. Cost-Effectiveness Analysis of Hormonal Therapies in Patients With Advanced Prostate Cancer in Italy. ISPOR 12th Annual European Congress, Paris, France, 24-27 October, 2009 Iannazzo S, Sacchi V. A Pharmacoeconomic Evaluation of...
